日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?

EMAX试验中关于长效支气管扩张剂治疗慢性阻塞性肺疾病的研究结果如何应用于基层医疗机构?

Kerwin, Edward M; Jones, Paul W; Bjermer, Leif H; Maltais, François; Boucot, Isabelle H; Naya, Ian P; Lipson, David A; Compton, Chris; Tombs, Lee; Vogelmeier, Claus F

Primary Care Management of Asthma Exacerbations or Attacks: Impact of the COVID-19 Pandemic

初级保健对哮喘急性发作或加重的管理:新冠疫情的影响

Fletcher, Monica; van der Molen, Thys; Lenney, Warren; Boucot, Isabelle; Aggarwal, Bhumika; Pizzichini, Emilio

New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management

新旧对比:吸入性皮质类固醇处方和剂量方案变化对哮喘管理的影响

Singh, Dave; Garcia, Gabriel; Maneechotesuwan, Kittipong; Daley-Yates, Peter; Irusen, Elvis; Aggarwal, Bhumika; Boucot, Isabelle; Berend, Norbert

Correction to: New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management

更正:新旧对比:吸入性皮质类固醇处方和剂量方案变化对哮喘管理的影响

Singh, Dave; Garcia, Gabriel; Maneechotesuwan, Kittipong; Daley-Yates, Peter; Irusen, Elvis; Aggarwal, Bhumika; Boucot, Isabelle; Berend, Norbert

Future concepts in bronchodilation for COPD: dual- versus monotherapy

慢性阻塞性肺疾病支气管扩张治疗的未来理念:双重疗法与单一疗法

Singh, Dave; Donohue, James F; Boucot, Isabelle H; Barnes, Neil C; Compton, Chris; Martinez, Fernando J

Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial

根据筛选时气流受限可逆程度评估乌美溴铵/维兰特罗的疗效:EMAX试验的事后分析

Vogelmeier, Claus F; Jones, Paul W; Kerwin, Edward M; Boucot, Isabelle H; Maltais, François; Tombs, Lee; Compton, Chris; Lipson, David A; Bjermer, Leif H

Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD: A Prespecified Analysis of The EMAX Trial

乌美溴铵/维兰特罗治疗现吸烟者和既往吸烟者慢性阻塞性肺疾病患者的疗效和安全性:EMAX试验的预设分析

Bjermer, Leif H; Boucot, Isabelle H; Vogelmeier, Claus F; Maltais, François; Jones, Paul W; Tombs, Lee; Compton, Chris; Lipson, David A; Kerwin, Edward M

The impact of fluticasone furoate/vilanterol on healthcare resource utilisation in the Salford Lung Study in chronic obstructive pulmonary disease

氟替卡松糠酸酯/维兰特罗对索尔福德肺病研究中慢性阻塞性肺疾病患者医疗资源利用的影响

Bakerly, Nawar Diar; Browning, Dominy; Boucot, Isabelle; Crawford, Jodie; McCorkindale, Sheila; Stein, Norman; New, John P

Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trial

沙丁胺醇的使用与慢性阻塞性肺疾病维持性支气管扩张剂疗效的关系:EMAX试验的前瞻性亚组分析

Maltais, F; Naya, I P; Vogelmeier, C F; Boucot, I H; Jones, P W; Bjermer, L; Tombs, L; Compton, C; Lipson, D A; Kerwin, E M

Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial

在慢性阻塞性肺疾病(COPD)治疗中,乌美溴铵/维兰特罗联合治疗较单药治疗可早期且持续改善症状:EMAX随机对照试验的事后分析

Kerwin, Edward M; Boucot, Isabelle H; Vogelmeier, Claus F; Maltais, Francois; Naya, Ian P; Tombs, Lee; Jones, Paul W; Lipson, David A; Keeley, Tom; Bjermer, Leif